FBFrank Benesch-Lee

Frank Benesch-Lee

*This is an algorithmically generated author record based on publicly available information.

Frank Benesch-Lee has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors

    by Cristina Borselli, Hannah Storrie, Frank Benesch-Lee, Dmitry Shvartsman, Christine Cezar, Jeff W. Lichtman, Herman H. Vandenburgh, David J. Mooney

    Regenerative efforts typically focus on the delivery of single factors, but it is likely that multiple factors regulating distinct aspects of the regenerative process (e.g., vascularization and stem cell activation) can be used in parallel to affect regeneration of functional tissues. This possibility was addressed in the context of ischemic muscle injury, which typically leads to necrosis and loss of tissue and function. The role of sustained delivery, via injectable gel, of a combination of VEGF to promote angiogenesis and insulin-like growth factor-1 (IGF1) to directly promote muscle regeneration and the return of muscle function in ischemic rodent hindlimbs was investigated. Sustained VEGF delivery alone led to neoangiogenesis in ischemic limbs, with complete return of tissue perfusion to normal levels by 3 weeks, as well as protection from hypoxia and tissue necrosis, leading to an improvement in muscle contractility. Sustained IGF1 delivery alone was found to enhance muscle fiber regeneration and protected cells from apoptosis. However, the combined delivery of VEGF and IGF1 led to parallel angiogenesis, reinnervation, and myogenesis; as satellite cell activation and proliferation was stimulated, cells were protected from apoptosis, the inflammatory response was muted, and highly functional muscle tissue was formed. In contrast, bolus delivery of factors did not have any benefit in terms of neoangiogenesis and perfusion and had minimal effect on muscle regeneration. These results support the utility of simultaneously targeting distinct aspects of the regenerative process.


  • T.P.4.04 Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts

    by H. Vandenburgh, J. Shansky, F. Benesch-Lee, K. Skelly, J. Spinazzola, Y. Saponjian, B.S. Tseng


  • Open Access

    Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts

    by Herman Vandenburgh, Janet Shansky, Frank Benesch-Lee, Kirsten Skelly, Janelle M. Spinazzola, Yero Saponjian, Brian S. Tseng

    Identification of factors that improve muscle function in boys with Duchenne muscular dystrophy (DMD) could lead to an improved quality of life. To establish a functional in vitro assay for muscle strength, mdx murine myoblasts, the genetic homologue of DMD, were tissue engineered in 96‐microwell plates into 3‐dimensional muscle constructs with parallel arrays of striated muscle fibers. When electrically stimulated, they generated tetanic forces measured with an automated motion tracking system. Thirty‐one compounds of interest as potential treatments for patients with DMD were tested at 3 to 6 concentrations. Eleven of the compounds (insulin‐like growth factor‐1, creat‐ine, β‐hydroxy‐β‐methylbutyrate, trichostatin A, lisino‐pril, and 6 from the glucocorticoid family) significantly increased tetanic force relative to placebo‐treated controls. The glucocorticoids methylprednisolone, deflazacort, and prednisone increased tetanic forces at low doses (EC 50 of 6, 19, and 56 nM, respectively), indicating a direct muscle mechanism by which they may be benefitting DMD patients. The tetanic force assay also identified beneficial compound interactions (arginine plus deflazacort and prednisone plus creatine) as well as deleterious interactions (prednisone plus creatine inhibited by pentoxifylline) of combinatorial therapies taken by some DMD patients. Since mdx muscle in vivo and DMD patients respond in a similar manner to many of these compounds, the in vitro assay will be a useful tool for the rapid identification of new potential treatments for muscle weakness in DMD and other muscle disorders.—Vandenburgh, H., Shansky, J., Benesch‐Lee, F., Skelly, K., Spinazzola, J.M., Saponjian, Y., Tseng, B.S. Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts. FASEB J . 23, 3325–3334 (2009). www.fasebj.org


  • Drug‐screening platform based on the contractility of tissue‐engineered muscle

    by Herman Vandenburgh, Janet Shansky, Frank Benesch‐Lee, Victoria Barbata Ba, Jonathan Reid, Lieven Thorrez, Robert Valentini, Gregory Crawford

    A tissue‐based approach to in vitro drug screening allows for determination of the cumulative positive and negative effects of a drug at the tissue rather than the cellular or subcellular level. Skeletal muscle myoblasts were tissue‐engineered into three‐dimensional muscle with parallel myofibers generating directed forces. When grown attached to two flexible microposts (μposts) acting as artificial tendons in a 96‐well plate format, the miniature bioartificial muscles (mBAMs) generated tetanic (active) forces upon electrical stimulation measured with a novel image‐based motion detection system. mBAM myofiber hypertrophy and active force increased in response to insulin‐like growth factor 1. In contrast, mBAM deterioration and weakness was observed with a cholesterol‐lowering statin. The results described in this study demonstrate the integration of tissue engineering and biomechanical testing into a single platform for the screening of compounds affecting muscle strength. Muscle Nerve, 2007


  • Ultrafast tabletop laser-pump–x-ray probe measurement of solvated Fe(CN)64−

    by Taewoo Lee, Yan Jiang, Christoph G. Rose-Petruck, Frank Benesch

    We report on the first ultrafast laser-pump–picosecond x-ray probe measurements of solvated transition metal complexes carried out with a tabletop ultrafast laser-driven plasma x-ray source. The x-ray absorption fine structure (XAFS) spectra of Fe(CN)64− solvated in water have been measured before and tens of picoseconds after photoexcitation with ultrashort UV laser pulses. The XAFS spectra after photoexcitation exhibits a K-edge shift indicating the increase of the iron-ligand distances. Reference spectra of Fe(CN)64− and Fe(CN)63− measured at a synchrotron source yield structural data that show static solvation-induced bond length changes of the metal complexes.


  • Ultrafast laboratory-based x-ray sources and their applications in chemical research

    by Taewoo Lee, Yan Jiang, Frank Benesch, Christoph G. Rose-Petruck

    Ultrafast high-intensity laser pulses incident upon condensed matter targets can generate high-density plasmas that emit x-ray pulses with sub-picosecond temporal structure, significant spatial coherence, and high brightness at kilohertz repetition rates. Such laser-driven plasma x-ray sources based on solid and liquid metal targets have been developed in our laboratory. Essential performance features are discussed along with a feasibility evaluation for future routine application in chemical research. Laser-driven x-ray sources are usable for ultrafast x-ray diffraction and ultrafast x-ray absorption spectroscopy. X-ray absorption near-edge spectra of solvated transition metal complexes are presented. Ultrafast molecular dynamics depends on the structure of the solvated molecule before photo-excitation. This solvation structure, in turn, depends on the solute's interaction with the solvent molecules. Furthermore, the solute's vibrational modes and its structure are correlated, solvent dependent, and can be measured by mid-infrared and x-ray absorption spectroscopy. Such measured spectra are presented and correlated with quantum calculations in order to elucidate the solvation environment of various transition metal coordination complexes.